The DOI matches its Crossref record; 57 of the 57 references it cites were found in a registry or an index.
Mechanisms of resistance to quinolones: target alterations, decreased accumulation and DNA gyrase protection
Abstract
Quinolones are broad-spectrum antibacterial agents, commonly used in both clinical and veterinary medicine. Their extensive use has resulted in bacteria rapidly developing resistance to these agents. Two mechanisms of quinolone resistance have been established to date: alterations in the targets of quinolones, and decreased accumulation due to impermeability of the membrane and/or an overexpression of efflux pump systems. Recently, mobile elements have also been described, carrying the qnr gene, which confers resistance to quinolones.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DNA gyrase, topoisomerase IV, and the 4-quinolones.
Drlica, K., & Zhao, X. (1997) · Microbiology and molecular biology reviews : MMBR · doi:10.1128/.61.3.377-392.1997 · Cited by 1,494
Quinolone resistance from a transferable plasmid
Martínez-Martínez, L., Pascual, A., & Jacoby, G. A. (1998) · The Lancet · doi:10.1016/s0140-6736(97)07322-4 · Cited by 1,100
Multidrug efflux pumps of gram-negative bacteria
Nikaido, H. (1996) · Journal of Bacteriology · doi:10.1128/jb.178.20.5853-5859.1996 · Cited by 1,082
Nalidixic acid resistance: A second genetic character involved in DNA gyrase activity
Gellert, M., Mizuuchi, K., O'Dea, M. H., Itoh, T., & Tomizawa, J.-I. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.11.4772 · Cited by 833
Molecular Properties of Bacterial Multidrug Transporters
Putman, M., van Veen, H. W., & Konings, W. N. (2000) · Microbiology and Molecular Biology Reviews · doi:10.1128/mmbr.64.4.672-693.2000 · Cited by 795
Sugino, A., Peebles, C. L., Kreuzer, K. N., & Cozzarelli, N. R. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.11.4767 · Cited by 784
Quinolone resistance-determining region in the DNA gyrase gyrB gene of Escherichia coli
Yoshida, H., Bogaki, M., Nakamura, M., Yamanaka, L. M., & Nakamura, S. (1991) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.35.8.1647 · Cited by 777
Antimicrobial resistance in developing countries
Hart, C. A., & Kariuki, S. (1998) · BMJ · doi:10.1136/bmj.317.7159.647 · Cited by 745
Analysis of a Complete Library of Putative Drug Transporter Genes in Escherichia coli
Nishino, K., & Yamaguchi, A. (2001) · Journal of Bacteriology · doi:10.1128/jb.183.20.5803-5812.2001 · Cited by 666
Magnet, S., Courvalin, P., & Lambert, T. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3375-3380.2001 · Cited by 575
Mechanism of plasmid-mediated quinolone resistance
Tran, J. H., & Jacoby, G. A. (2002) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.082092899 · Cited by 564
CmeABC Functions as a Multidrug Efflux System in Campylobacter jejuni
Lin, J., Michel, L. O., & Zhang, Q. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.7.2124-2131.2002 · Cited by 528
Yoshida, H., Bogaki, M., Nakamura, S., Ubukata, K., & Konno, M. (1990) · Journal of Bacteriology · doi:10.1128/jb.172.12.6942-6949.1990 · Cited by 479
Regulation of chromosomally mediated multiple antibiotic resistance: the mar regulon
Alekshun, M. N., & Levy, S. B. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.10.2067 · Cited by 470
Ciprofloxacin: An Updated Review of its Pharmacology, Therapeutic Efficacy and Tolerability
Davis, R., Markham, A., & Balfour, J. A. (1996) · Drugs · doi:10.2165/00003495-199651060-00010 · Cited by 389
Topoisomerase IV is a target of quinolones in Escherichia coli.
Khodursky, A. B., Zechiedrich, E. L., & Cozzarelli, N. R. (1995) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.92.25.11801 · Cited by 378
Cohen, S. P., McMurry, L. M., Hooper, D. C., Wolfson, J. S., & Levy, S. B. (1989) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.33.8.1318 · Cited by 376
Everett, M. J., Jin, Y. F., Ricci, V, & Piddock, L. J. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.10.2380 · Cited by 365
Contribution of the MexX-MexY-OprM Efflux System to Intrinsic Resistance in Pseudomonas aeruginosa
Masuda, N., Sakagawa, E., Ohya, S., Gotoh, N., Tsujimoto, H., & Nishino, T. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.9.2242-2246.2000 · Cited by 279
Expression in Escherichia coli of a New Multidrug Efflux Pump, MexXY, from Pseudomonas aeruginosa
Mine, T., Morita, Y., Kataoka, A., Mizushima, T., & Tsuchiya, T. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.2.415 · Cited by 274
Permeability of Pseudomonas aeruginosa outer membrane to hydrophilic solutes
Yoshimura, F., & Nikaido, H. (1982) · Journal of Bacteriology · doi:10.1128/jb.152.2.636-642.1982 · Cited by 274
Academic Detailing to Improve Use of Broad-Spectrum Antibiotics at an Academic Medical Center
Solomon, D. H., Van Houten, L., Glynn, R. J., Baden, L., Curtis, K., Schrager, H., & Avorn, J. (2001) · Archives of Internal Medicine · doi:10.1001/archinte.161.15.1897 · Cited by 270
Angus, B. L., Carey, A. M., Caron, D. A., Kropinski, A. M., & Hancock, R. E. (1982) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.21.2.299 · Cited by 262
Gill, M. J., Brenwald, N. P., & Wise, R. (1999) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.43.1.187 · Cited by 259
Routes of quinolone permeation in Escherichia coli
Chapman, J. S., & Georgopapadakou, N. H. (1988) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.32.4.438 · Cited by 253
Pan, X. S., & Fisher, L. M. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.2.471 · Cited by 237
Ng, E. Y., Trucksis, M., & Hooper, D. C. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.8.1881 · Cited by 232
Quinolone-resistant mutations of the gyrA gene of Escherichia coli
Yoshida, H., Kojima, T., Yamagishi, J.-I., & Nakamura, S. (1988) · Molecular and General Genetics MGG · doi:10.1007/bf00338386 · Cited by 221
Mapping the active site tyrosine of Escherichia coli DNA gyrase.
Horowitz, D. S., & Wang, J. C. (1987) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)61193-7 · Cited by 217
Prevalence of Plasmid-Mediated Quinolone Resistance
Jacoby, G. A., Chow, N., & Waites, K. B. (2003) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.47.2.559-562.2003 · Cited by 209
Grangie, J.-D., Roulot, D., Pelletier, G., Pariente, É.-A., Denis, J., Ink, O., Blanc, P., Richardet, J. P., Vinel, J. P., Delisle, F., et al. (1998) · Journal of Hepatology · doi:10.1016/s0168-8278(98)80061-5 · Cited by 200
Baucheron, S., Imberechts, H., Chaslus-Dancla, E., & Cloeckaert, A. (2002) · Microbial Drug Resistance · doi:10.1089/10766290260469543 · Cited by 186
Multiple antibiotic resistance in Stenotrophomonas maltophilia
Alonso, A., & Martínez, J. L. (1997) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.41.5.1140 · Cited by 177
Ahmed, M., Lyass, L., Markham, P. N., Taylor, S. S., Vázquez-Laslop, N., & Neyfakh, A. A. (1995) · Journal of Bacteriology · doi:10.1128/jb.177.14.3904-3910.1995 · Cited by 177
Hakanen, A., Kotilainen, P., Jalava, J., Siitonen, A., & Huovinen, P. (1999) · Journal of Clinical Microbiology · doi:10.1128/jcm.37.11.3572-3577.1999 · Cited by 175
Chou, J. H., Greenberg, J. T., & Demple, B. (1993) · Journal of Bacteriology · doi:10.1128/jb.175.4.1026-1031.1993 · Cited by 171
PLASMID-MEDIATED RESISTANCE TO NALIDIXIC ACID IN SHIGELLA DYSENTERIAE TYPE 1
Munshi, M. H., Haider, K., Rahaman, M. M., Sack, D., Ahmed, Z. U., & Morshed, M. G. (1987) · The Lancet · doi:10.1016/s0140-6736(87)90957-3 · Cited by 166
Oethinger, M., Podglajen, I., Kern, W. V., & Levy, S. B. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.8.2089 · Cited by 164
Quinolone resistance mutations in the DNA gyrase gyrA and gyrB genes of Staphylococcus aureus
Ito, H., Yoshida, H., Bogaki-Shonai, M., Niga, T., Hattori, H., & Nakamura, S. (1994) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.38.9.2014 · Cited by 158
Jones, M. E., Sahm, D. F., Martin, N., Scheuring, S., Heisig, P., Thornsberry, C., Köhrer, K., & Schmitz, F.-J. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.2.462-466.2000 · Cited by 158
Schmitz, F., Jones, M. E., Hofmann, B., Hansen, B., Scheuring, S., Lückefahr, M., Fluit, A. C., Verhoef, J., Hadding, U., Heinz, H., et al. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.5.1249 · Cited by 137
Takei, M., Fukuda, H., Kishii, R., & Hosaka, M. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.12.3544-3547.2001 · Cited by 123
Expression of Multidrug Efflux Pump SmeDEF by Clinical Isolates of Stenotrophomonas maltophilia
Alonso, A., & Martínez, J. L. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.6.1879-1881.2001 · Cited by 121
Bachoual, R., Ouabdesselam, S., Mory, F., Lascols, C., Soussy, C., & Tankovic, J. (2001) · Microbial Drug Resistance · doi:10.1089/10766290152652800 · Cited by 106
Ferrándiz, M.-J., Fenoll, A., Liñares, J., & de la Campa, A. G. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.4.840-847.2000 · Cited by 91
Ribera, A., Ruiz, J., de Anta, M. T. J., & Vilà, J. (2002) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/49.4.697 · Cited by 91
Self-citationZhao, Q., Li, X.-Z., Srikumar, R., & Poole, K. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.7.1682 · Cited by 89
Quinolone-resistant mutants of escherichia coli DNA topoisomerase IV parC gene
Kumagai, Y., Kato, J., Hoshino, K., Akasaka, T., Sato, K., & Ikeda, H. (1996) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.40.3.710 · Cited by 88
Renau, T. E., Léger, R., Yen, R., She, M. W., Flamme, E. M., Sangalang, J. C., Gannon, C. L., Chamberland, S., Lomovskaya, O., & LEE, V. J. (2002) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/s0960-894x(02)00006-9 · Cited by 78
Janoir, C., Podglajen, I., Kitzis, M.-D., Poyart, C., & Gutmann, L. (1999) · The Journal of Infectious Diseases · doi:10.1086/314888 · Cited by 72
İnce, D., & Hooper, D. C. (2001) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.45.10.2755-2764.2001 · Cited by 71
Fournier, B., & Hooper, D. C. (1998) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.42.1.121 · Cited by 70
Norfloxacin resistance in a clinical isolate of Escherichia coli
Aoyama, H., Sato, K., Kato, T., Hirai, K., & Mitsuhashi, S. (1987) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.31.10.1640 · Cited by 69
Valdezate, S., Vindel, A., Echeíta, A., Baquero, F., & Cantón, R. (2002) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.46.3.665-671.2002 · Cited by 57
Guérin, F., Varon, E., Buu-Hoï, A., Gutmann, L., & Podglajen, I. (2000) · Antimicrobial Agents and Chemotherapy · doi:10.1128/aac.44.8.2197-2200.2000 · Cited by 41
Roychoudhury, S. (2001) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/48.1.29 · Cited by 40
Ribera, A., Jurado, A., Ruiz, J., Marco, F., del Valle, O., Mensa, J., Chaves, J., Hernández, G., de Anta, M. T. J., & Vilà, J. (2002) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/s0732-8893(01)00335-2 · Cited by 27
Self-citation
Cited by
Clinical relevance of the ESKAPE pathogens
Pendleton, J. N., Gorman, S. P., & Gilmore, B. F. (2013) · Expert Review of Anti-infective Therapy · doi:10.1586/eri.13.12 · Cited by 1,423
Acquired Antibiotic Resistance Genes: An Overview
van Hoek, A. H. A. M., Mevius, D., Guerra, B., Mullany, P., Roberts, A. P., & Aarts, H. J. M. (2011) · Frontiers in Microbiology · doi:10.3389/fmicb.2011.00203 · Cited by 1,136
The worldwide emergence of plasmid-mediated quinolone resistance
Robicsek, A., Jacoby, G. A., & Hooper, D. C. (2006) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(06)70599-0 · Cited by 966
Evolutionary paths to antibiotic resistance under dynamically sustained drug selection
Toprak, E., Veres, A., Michel, J.-B., Chait, R., Hartl, D. L., & Kishony, R. (2012) · Nature Genetics · doi:10.1038/ng.1034 · Cited by 764
Antibiotic resistance and extended spectrum beta-lactamases: Types, epidemiology and treatment
Shaikh, S., Fatima, J., Shakil, S., Rizvi, S. M. D., & Kamal, M. A. (2015) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2014.08.002 · Cited by 758
Metadata
- Authors
- Ruiz, J.
- Venue
- Journal of Antimicrobial Chemotherapy
- Publisher
- Oxford University Press (OUP)
- Published
- 2003-04-14
- Volume
- 51
- Issue
- 5
- Pages
- 1109-1117
- ISSN
- 0305-7453 (ISSN-L)
- 1460-2091
- OpenAlex
- W2126326498
- Cited by
- 711
- References
- 57
- FWCI
- 8.70
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.